— Know what they know.
Not Investment Advice

HALB OTC

Halberd Corporation
1W: +100.0% 1M: +122.2% 3M: +100.0% YTD: +33.3% 1Y: -13.0% 3Y: -77.8% 5Y: -93.7%
$0.00
+0.00 (+81.82%)
 
Weekly Expected Move ±54.3%
$-0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $1.0M mcap · 260M float · 0.307% daily turnover · Short 57% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$549 -165.2% ▼
Operating Income
-$19K +75.1% ▲
Net Income
-$20K +74.8% ▲
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
-$18K +75.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$5K$8K$3K$999$0
YoY Growth+0.0%+53.1%-66.0%-63.3%-100.0%
Cost of Revenue$4K$214$1K$1K$549
Gross Profit$943$8K$1K-$207-$549
Gross Margin18.0%97.3%48.4%-20.7%—
R&D Expenses$688K$913K$296K$67K$6K
SG&A Expenses$168K$713K$153K$8K$12K
Operating Expenses$857K$2M$449K$75K$18K
Operating Income-$856K-$2M-$447K-$75K-$19K
Operating Margin-16336.0%-20182.4%-16410.8%-7512.5%—
Interest Expense$6K$6K$7K$5K$1K
Income Before Tax-$862K-$2M-$454K-$80K-$20K
Tax Expense$0$0$0$0$0
Net Income-$862K-$2M-$454K-$80K-$20K
Net Margin-16447.8%-20258.7%-16663.2%-7975.6%—
EPS (Diluted)$-0.00$-0.00$-0.00$-0.00$0.00
EBITDA$85K-$2M-$446K-$74K-$18K
Shares Outstanding393M512M537M636M636M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms